genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Bipolar disorder
News
Genomic Signatures Clearly Dictate Schizophrenic Drug Responses
Industry News
Allergan, Richter Stay Committed to Cariprazine Despite Phase III Failure
News
Autism and Bipolar Disorder Share Common Genetic Roots
News
Broad Institute Wins $650M Commitment to Psychiatric Research
News
Drug Marketing Claims Cost GSK Again
News
Stem Cell Study Sheds First Light on Bipolar Disorder
News
Rockefeller University’s C. David Allis Wins Japan Prize
News
Merck Axes 152 in Saphris Sales Force after Selling U.S. Rights
News
Forest Spends $240M to Acquire Marketing Rights to Saphris from Merck
News
GEN Reports on Downfall of a Once Biotech King
1
2
3
4
...
7
Page 3 of 7
Scroll Up
Scroll Up
